ARTICLE SUMMARY:
Mexico’s regulatory authority, COFEPRIS, is promising big improvements in its medical device review times. But manufacturers should take advantage of the opportunities as soon as possible, as the efficiencies probably won’t be sustainable, explains Miguel Angel Torres Tello, from the Mexico City-based firm Veraque, in this edition of Consultants Corner.
Mexico’s government advanced policies over the summer that commit to significantly speeding up device premarket review times. Companies should try to leverage the new efficiencies as soon as possible, however, because there is no guarantee they will last.
That’s the message from Miguel Angel Torres Tello, a veteran Mexico City-based regulatory affairs consultant, who, in a recent interview with Market Pathways, says he has seen this cycle before. “My point to industry is use it right now,” Tello, co-founder of Veraque Consulting Services, says of the newly promised pathways and timelines. “If you wait, … eventually they will start having delays.”
